The promise of microarrays in the management and treatment of breast cancer

Jenny C. Chang; Susan G. Hilsenbeck; Suzanne A.W. Fuqua

doi:10.1186/bcr1018

The promise of microarrays in the management and treatment of breast cancer

Jenny C. Chang, Susan G. Hilsenbeck, Suzanne A.W. Fuqua

Research output: Contribution to journal › Review article › peer-review

25 Scopus citations

Abstract

Breast cancer is the most common malignancy afflicting women from Western cultures. Developments in breast cancer molecular and cellular biology research have brought us closer to understanding the genetic basis of this disease. Recent advances in microarray technology hold the promise of further increasing our understanding of the complexity and heterogeneity of this disease, and providing new avenues for the prognostication and prediction of breast cancer outcomes. These new technologies have some limitations and have yet to be incorporated into clinical use, for both the diagnosis and treatment of women with breast cancer. The most recent application of microarray genomic technologies to studying breast cancer is the focus of this review.

Original language	English (US)
Pages (from-to)	100-104
Number of pages	5
Journal	Breast Cancer Research
Volume	7
Issue number	3
DOIs	https://doi.org/10.1186/bcr1018
State	Published - May 2005

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.1186/bcr1018

Cite this

@article{5653341bd4ed49fd9c8268a90aba383f,

title = "The promise of microarrays in the management and treatment of breast cancer",

abstract = "Breast cancer is the most common malignancy afflicting women from Western cultures. Developments in breast cancer molecular and cellular biology research have brought us closer to understanding the genetic basis of this disease. Recent advances in microarray technology hold the promise of further increasing our understanding of the complexity and heterogeneity of this disease, and providing new avenues for the prognostication and prediction of breast cancer outcomes. These new technologies have some limitations and have yet to be incorporated into clinical use, for both the diagnosis and treatment of women with breast cancer. The most recent application of microarray genomic technologies to studying breast cancer is the focus of this review.",

author = "Chang, {Jenny C.} and Hilsenbeck, {Susan G.} and Fuqua, {Suzanne A.W.}",

year = "2005",

month = may,

doi = "10.1186/bcr1018",

language = "English (US)",

volume = "7",

pages = "100--104",

journal = "Breast Cancer Research",

issn = "1465-5411",

publisher = "BioMed Central",

number = "3",

}

TY - JOUR

T1 - The promise of microarrays in the management and treatment of breast cancer

AU - Chang, Jenny C.

AU - Hilsenbeck, Susan G.

AU - Fuqua, Suzanne A.W.

PY - 2005/5

Y1 - 2005/5

N2 - Breast cancer is the most common malignancy afflicting women from Western cultures. Developments in breast cancer molecular and cellular biology research have brought us closer to understanding the genetic basis of this disease. Recent advances in microarray technology hold the promise of further increasing our understanding of the complexity and heterogeneity of this disease, and providing new avenues for the prognostication and prediction of breast cancer outcomes. These new technologies have some limitations and have yet to be incorporated into clinical use, for both the diagnosis and treatment of women with breast cancer. The most recent application of microarray genomic technologies to studying breast cancer is the focus of this review.

AB - Breast cancer is the most common malignancy afflicting women from Western cultures. Developments in breast cancer molecular and cellular biology research have brought us closer to understanding the genetic basis of this disease. Recent advances in microarray technology hold the promise of further increasing our understanding of the complexity and heterogeneity of this disease, and providing new avenues for the prognostication and prediction of breast cancer outcomes. These new technologies have some limitations and have yet to be incorporated into clinical use, for both the diagnosis and treatment of women with breast cancer. The most recent application of microarray genomic technologies to studying breast cancer is the focus of this review.

UR - http://www.scopus.com/inward/record.url?scp=18844483267&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=18844483267&partnerID=8YFLogxK

U2 - 10.1186/bcr1018

DO - 10.1186/bcr1018

M3 - Review article

C2 - 15987438

AN - SCOPUS:18844483267

SN - 1465-5411

VL - 7

SP - 100

EP - 104

JO - Breast Cancer Research

JF - Breast Cancer Research

IS - 3

ER -

The promise of microarrays in the management and treatment of breast cancer

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this